Prognostic role of fibrinogen-to-albumin ratio in patients with gynecological cancers: a meta-analysis
Authors:
Open Access
- 3 July 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1580940
Abstract
Background: Fibrinogen-to-albumin ratio (FAR) has been widely studied for its prognostic value in gynecological cancers, but the results remain inconsistent. Therefore, this study aimed to evaluate the precise prognostic significance of FAR in gynecological cancers.Methods: A comprehensive literature search was conducted in PubMed, Web of Science, Embase, the Cochrane Library, and China National Knowledge Infrastructure (CNKI) databases up to 12 May 2025. The prognostic value of FAR for overall survival (OS) and progression-free survival (PFS) in gynecological cancers was examined using pooled hazard ratios (HRs) and corresponding 95% confidence intervals (CIs).Results: A total of 10 articles comprising 1,902 patients were included in this meta-analysis. Pooled results indicated that elevated FAR was significantly associated with poor OS (HR = 2.75, 95% CI: 2.26–3.36, p < 0.001) and shorter PFS (HR = 1.60, 95% CI: 1.20–2.12, p = 0.001) in patients with gynecological cancers. Subgroup analyses confirmed that FAR predicted OS regardless of sample size, cancer type, FIGO stage, treatment modality, FAR threshold, threshold determination method, or type of survival analysis (p < 0.05). Additionally, FAR remained a significant predictor of poor PFS across different cancer types.Conclusion: This meta-analysis showed that a high FAR is significantly associated with worse OS and PFS in patients with gynecological cancers. FAR may serve as a promising prognostic biomarker in clinical practice.Systematic review registration: https://inplasy.com/inplasy-2025-5-0036/, identifier INPLASY202550036.Keywords
This publication has 38 references indexed in Scilit:
- Epidemiological trends and risk factors of gynecological cancers: an updateMedical Oncology, 2023
- A low preoperative albumin-to-globulin ratio is a negative prognostic factor in patients with surgically treated cervical cancerInternational Journal of Clinical Oncology, 2021
- Relationship of Nutritional Status, Inflammation, and Serum Albumin Levels During Acute Illness: A Prospective StudyThe American Journal of Medicine, 2020
- Systemic immune inflammation index is a promising non-invasive marker for the prognosis of the patients with localized renal cell carcinomaInternational Urology and Nephrology, 2020
- Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomesClinical & Experimental Metastasis, 2019
- Fibrinogen and fibrin: An illustrated reviewResearch and Practice in Thrombosis and Haemostasis, 2019
- Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal CancerJAMA Oncology, 2017
- Preoperative hypoalbuminemia is associated with worse outcomes in colon cancer patientsClinical Nutrition, 2017
- Albumin in chronic liver disease: structure, functions and therapeutic implicationsHepatology International, 2015
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010